The role of pro- and anti-inflammatory cytokines in the pathogenesis of spontaneous canine CNS diseases

Veterinary Immunology and Immunopathology

Volumn 147, Issue 1-2, 2012, Pages 6-24

  Spitzbarth, I ^a   Baumgartner W ^a   Beineke, A ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Canine distemper; Central nervous system; Cytokines; Dog; Microglia; Spinal cord injury; Steroid responsive meningitis arteritis

Indexed keywords

CYTOKINE; MYELIN;

BRAIN VASCULITIS; CENTRAL NERVOUS SYSTEM DISEASE; DISTEMPER LEUKOENCEPHALITIS; DOG; ENCEPHALOMYELITIS; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INTERVERTEBRAL DISK DISEASE; NONHUMAN; REVIEW; SPINAL CORD INJURY; STEROID RESPONSIVE MENINGITIS ARTERITIS;

ANIMALS; ARTERITIS; CENTRAL NERVOUS SYSTEM DISEASES; CYTOKINES; DISTEMPER; DOG DISEASES; DOGS; MENINGITIS; SPINAL CORD INJURIES;

CANIS FAMILIARIS; RODENTIA;

EID: 84860915471     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2012.04.005     Document Type: Review

References (169)

1. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature 1996, 383:787-793.
2. Alldinger S., Wünschmann A., Baumgärtner W., Voss C., Kremmer E. Up-regulation of major histocompatibility complex class II antigen expression in the central nervous system of dogs with spontaneous canine distemper virus encephalitis. Acta Neuropathol. 1996, 92:273-280.
3. Appel M.J. Canine distemper virus. Virus Infections of Vertebrates 1987, vol. 1:133-159. Elsevier Science Publishers B.V., Amsterdam, Oxford, New York, Tokyo.
4. Arend W.P. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J. Clin. Invest. 1991, 88:1445-1451.
5. Banwell V., Sena E.S., Macleod M.R. Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. J. Stroke Cerebrovasc. Dis. 2009, 18:269-276.
6. Bareyre F.M., Schwab M.E. Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays. Trends Neurosci. 2003, 26:555-563.
7. Bartholdi D., Schwab M.E. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur. J. Neurosci. 1997, 9:1422-1438.
8. Basu A., Krady J.K., Levison S.W. Interleukin-1: a master regulator of neuroinflammation. J. Neurosci. Res. 2004, 78:151-156.
9. Baumgärtner W., Alldinger S. The pathogenesis of canine distemper virus induced demyelination-a biphasic process. Experimental Models of Multiple Sclerosis 2005, 871-887. Springer, New York. E. Lavi, C.S. Constantinescu (Eds.).
10. Baumgärtner W., örvell C., Reinacher M. Naturally occurring canine distemper virus encephalitis: distribution and expression of viral polypeptides in nervous tissues. Acta Neuropathol. 1989, 78:504-512.
11. Beineke A., Markus S., Borlak J., Thum T., Baumgärtner W. Increase of pro-inflammatory cytokine expression in non-demyelinating early cerebral lesions in nervous canine distemper. Viral Immunol. 2008, 21:401-410.
12. Beineke A., Puff C., Seehusen F., Baumgärtner W. Pathogenesis and immunopathology of systemic and nervous canine distemper. Vet. Immunol. Immunopathol. 2009, 127:1-18.
13. Bertolotto A., Capobianco M., Malucchi S., Manzardo E., Audano L., Bergui M., Bradac G.B., Mutani R. Transforming growth factor beta1 (TGFbeta1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patients. Neurosci. Lett. 1999, 263:21-24.
14. Beyer M., Gimsa U., Eyüpoglu I.Y., Hailer N.P., Nitsch R. Phagocytosis of neuronal or glial debris by microglial cells: upregulation of MHC class II expression and multinuclear giant cell formation in vitro. Glia 2000, 31:262-266.
15. Boekhoff T.M., Ensinger E.M., Carlson R., Bock P., Baumgärtner W., Rohn K., Tipold A., Stein V.M. Microglial contribution to secondary injury evaluated in a large animal model of human spinal cord trauma. J. Neurotrauma 2012, 29:1000-1011.
16. Bomstein Y., Marder J.B., Vitner K., Smirnov I., Lisaey G., Butovsky O., Fulga V., Yoles E. Features of skin-coincubated macrophages that promote recovery from spinal cord injury. J. Neuroimmunol. 2003, 142:10-16.
17. Bray J.P., Burbidge H.M. The canine intervertebral disk. Part two. Degenerative changes-nonchondrodystrophoid versus chondrodystrophoid disks. J. Am. Anim. Hosp. Assoc. 1998, 34:135-144.
18. Brewer K.L., Bethea J.R., Yezierski R.P. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Exp. Neurol. 1999, 159:484-493.
19. Briere F., Bridon J.M., Chevet D., Souillet G., Bienvenu F., Guret C., Martinez-Valdez H., Banchereau J. Interleukin 10 induces B lymphocytes from IgA deficient patients to secrete IgA. J. Clin. Invest. 1994, 94:97-104.
20. Brooks P.N. Necrotizing vasculitis in a group of Beagles. Lab. Anim. 1984, 18:285-290.
21. Brosnan C.F., Cannella B., Battistini L., Raine C.S. Cytokine localisation in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology 1995, 45:16-21.
22. Bsibsi M., Ravid R., Gveric D., van Noort J.M. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 2002, 61:1013-1021.
23. Burgener I., Van Ham L., Jaggy A., Vandevelde M., Tipold A. Chemotactic activity and IL-8 levels in the cerebrospinal fluid in canine steroid responsive meningitis-arteriitis. J. Neuroimmunol. 1998, 89:182-190.
24. Burns J.C., Felsburg P.J., Wilson H., Rosen F.S., Glickman L.T. Canine pain syndrome is a model for the study of Kawasaki disease. Perspect. Biol. Med. 1991, 35:68-73.
25. Calabresi P.A., Tranquill L.R., McFarland H.F., Cowan E.P. Cytokine gene expression in cells derived from CSF of multiple sclerosis patients. J. Neuroimmunol. 1998, 89:198-205.
26. Cizinauskas S., Jaggy A., Tipold A. Long-term treatment of dogs with steroid responsive meningitis-arteritis: clinical, laboratory and therapeutic results. J. Small Anim. Pract. 2000, 41:295-301.
27. David S., Kroner A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci. 2011, 12:388-399.
28. Deli M.A., Descamps L., Dehouck M.P., Cecchelli R., Joó F., Abrahám C.S., Torpier G. Exposure of tumor necrosis factor-alpha to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin. J. Neurosci. Res. 1995, 41:717-726.
29. Duchini A., Govindarajan S., Santucci M., Zampi G., Hofman F.M. Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. J. Investig. Med. 1996, 44:474-482.
30. Dunham S.P. Cytokines and anti-cytokine therapy: clinical potential for treatment of feline disease. J. Feline Med. Surg. 1999, 1:7-14.
31. Dusart I., Schwab M.E. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur. J. Neurosci. 1994, 6:712-724.
32. Ejrnaes M., von Herrath M.G. Cure of chronic viral infection by neutralizing antibody treatment. Autoimmun. Rev. 2007, 6:267-271.
33. Elenkov I.J. Glucocorticoids and the Th1/Th2 balance. Ann. N.Y. Acad. Sci. 2004, 1024:138-146.
34. Ensinger E.M., Boekhoff T.M., Carlson R., Beineke A., Rohn K., Tipold A., Stein V.M. Regional topographical differences of canine microglial immunophenotype and function in the healthy spinal cord. J. Neuroimmunol. 2010, 227:144-152.
35. Esposito E., Cuzzocrea S. TNFalpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma. Curr. Med. Chem. 2009, 16:3152-3167.
36. Esposito E., Cuzzocrea S. Anti-TNF therapy in the injured spinal cord. Trends Pharmacol. Sci. 2011, 32:107-115.
37. Felsburg P.J., Hogenesch H., Somberg R.L., Snyder P.W., Glickman L.T. Immunologic abnormalities in canine juvenile polyarteritis syndrome: a naturally occurring animal model of Kawasaki disease. Clin. Immunol. Immunopathol. 1992, 65:110-118.
38. Ferguson A.R., Christensen R.N., Gensel J.C., Miller B.A., Sun F., Beattie E.C., Bresnahan J.C., Beattie M.S. Cell death after spinal cord injury is exacerbated by rapid TNF alpha-induced trafficking of GluR2-lacking AMPARs to the plasma membrane. J. Neurosci. 2008, 28:11391-11400.
39. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 1991, 147:3815-3822.
40. Fleming J.C., Norenberg M.D., Ramsay D.A., Dekaban G.A., Marcillo A.E., Saenz A.D., Pasquale-Styles M., Dietrich W.D., Weaver L.C. The cellular inflammatory response in human spinal cords after injury. Brain 2006, 129:3249-3269.
41. Fletcher J.M., Lalor S.J., Sweeney C.M., Tubridy N., Mills K.H. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 2010, 162:1-11.
42. Fluehmann G., Doherr M.G., Jaggy A. Canine neurological diseases in a referral hospital population between 1989 and 2000 in Switzerland. J. Small Anim. Pract. 2006, 47:582-587.
43. Foster A.P. Immunomodulation and immunodeficiency. Vet. Dermatol. 2004, 15:115-126.
44. Fox R.J., Rostami A.M. Anti-interleukin-12 antibody: potential role in preventing relapses of multiple sclerosis. BioDrugs 2000, 13:233-241.
45. Frei K., Siepl C., Groscurth P., Bodmer S., Schwerdel C., Fontana A. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur. J. Immunol. 1987, 17:1271-1278.
46. Frisk A.L., Baumgärtner W., Gröne A. Dominating interleukin-10 mRNA expression induction in cerebrospinal fluid cells of dogs with natural canine distemper virus induced demyelinating and nondemyelinating CNS lesions. J. Neuroimmunol. 1999, 97:102-109.
47. Gangur V., Birmingham N.P., Thanesvorakul S. Chemokines in health and disease. Vet. Immunol. Immunopathol. 2002, 86:127-136.
48. Garden O.A., Pinheiro D., Cunningham F. All creatures great and small: regulatory T cells in mice, humans, dogs and other domestic animal species. Int. Immunopharmacol. 2010, 11:576-588.
49. Genovese T., Esposito E., Mazzon E., Di Paola R., Caminiti R., Bramanti P., Cappelani A., Cuzzocrea S. Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. J. Neurochem. 2009, 108:1360-1372.
50. Gensel J.C., Nakamura S., Guan Z., van Rooijen N., Ankeny D.P., Popovich P.G. Macrophages promote axon regeneration with concurrent neurotoxicity. J. Neurosci. 2009, 29:3956-3968.
51. Gensel J.C., Donnelly D.J., Popovich P.G. Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages. Expert Opin. Ther. Targets 2011, 15:505-518.
52. Gibson R.M., Rothwell N.J., Le Feuvre R.A. CNS injury: the role of the cytokine IL-1. Vet. J. 2004, 168:230-237.
53. Greer K.A., Daly P., Murphy K.E., Callanan J.J. Analysis of gene expression in brain tissue from Greyhounds with meningoencephalitis. Am. J. Vet. Res. 2010, 71:547-554.
54. Gröne A., Frisk A.L., Baumgärtner W. Cytokine mRNA expression in whole blood samples from dogs with natural canine distemper virus infection. Vet. Immunol. Immunopathol. 1998, 65:11-27.
55. Gröne A., Alldinger S., Baumgärtner W. Interleukin-1beta, -6, -12 and tumor necrosis factor-alpha expression in brains of dogs with canine distemper virus infection. J. Neuroimmunol. 2000, 110:20-30.
56. Gröne A., Fonfara S., Baumgärtner W. Cell type-dependent cytokine expression after canine distemper virus infection. Viral Immunol. 2002, 15:493-505.
57. Gröters S., Alldinger S., Baumgärtner W. Up-regulation of mRNA for matrix metalloproteinases-9 and -14 in advanced lesions of demyelinating canine distemper leukoencephalitis. Acta Neuropathol. 2005, 110:369-382.
58. Guyon A., Massa F., Rovère C., Nahon J.L. How cytokines can influence the brain: a role for chemokines?. J. Neuroimmunol. 2008, 198:46-55.
59. Hayes T.J., Roberts G.K., Halliwell W.H. An idiopathic febrile necrotizing arteritis syndrome in the dog: beagle pain syndrome. Toxicol. Pathol. 1989, 17:129-137.
60. Hogenesch H., Snyder P.W., Scott-Moncrieff J.C., Glickman L.T., Felsburg P.J. Interleukin-6 activity in dogs with juvenile polyarteritis syndrome: effect of corticosteroids. Clin. Immunol. Immunopathol. 1995, 77:107-110.
61. Hopkins S.J., Rothwell N.J. Cytokines and the nervous system. I. Expression and recognition. Trends Neurosci. 1995, 18:83-88.
62. Hauben E., Agranov E., Gothilf A., Nevo U., Cohen A., Smirnov I., Steinman L., Schwartz M. Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease. J. Clin. Invest. 2001, 108:591-599.
63. Jeffery N.D., Lakatos A., Franklin R.J. Autologous olfactory glial cell transplantation is reliable and safe in naturally occurring canine spinal cord injury. J. Neurotrauma 2005, 22:1282-1293.
64. Jeffery N.D., Smith P.M., Lakatos A., Ibanez C., Ito D., Franklin R.J. Clinical canine spinal cord injury provides an opportunity to examine the issues in translating laboratory techniques into practical therapy. Spinal Cord 2006, 44:584-593.
65. Jones T.B., Basso D.M., Sodhi A., Pan J.Z., Hart R.P., MacCallum R.C., Lee S., Whitacre C.C., Popovich P.G. Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J. Neurosci. 2002, 22:2690-2700.
66. Kigerl K.A., Popovich P.G. Toll-like receptors in spinal cord injury. Curr. Top. Microbiol. Immunol. 2009, 336:121-136.
67. Kigerl K.A., Lai W., Rivest S., Hart R.P., Satoskar A.R., Popovich P.G. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J. Neurochem. 2007, 102:37-50.
68. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 2009, 29:13435-13444.
69. Kiklya K., Liua L., Naa S., Sedgwicka J.D. The IL-23/Th17 axis: therapeutic targets for autoimmune inflammation. Curr. Opin. Immunol. 2006, 18:670-675.
70. Kim S., Steelman A.J., Koito H., Li J. Astrocytes promote TNF-mediated toxicity to oligodendrocyte precursors. J. Neurochem. 2011, 116:53-66.
71. Kimura A., Kishimoto T. Th17 cells in inflammation. Int. Immunopharmacol. 2011, 11:319-322.
72. Kipar A., Baumgärtner W., Vogl C., Gaedke K., Wellman M. Immunohistochemical characterization of inflammatory cells in brains of dogs with granulomatous meningoencephalitis. Vet. Pathol. 1998, 35:43-52.
73. Kipnis J., Avidan H., Caspi R.R., Schwartz M. Dual effect of CD4+ CD25+ regulatory T cells in neurodegeneration: a dialogue with microglia. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:14663-14669.
74. Kling J. Biotech for your companion?. Nat. Biotechnol. 2007, 25:1343-1345.
75. Klusman I., Schwab M.E. Effects of pro-inflammatory cytokines in experimental spinal cord injury. Brain Res. 1997, 762:173-184.
76. Krakowka S., Axthelm M.K., Johnson G.C. Canine distemper virus. Comparative Pathobiology of Viral Diseases 1985, vol. 2:137-164. CRC Press, Boca Raton.
77. Kwon B.K., Stammers A.M., Belanger L.M., Bernardo A., Chan D., Bishop C.M., Slobogean G.P., Zhang H., Umedaly H., Giffin M., Street J., Boyd M.C., Paquette S.J., Fisher C.G., Dvorak M.F. Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury. J. Neurotrauma 2010, 27:669-682.
78. Lamb R.A., Kolakofsky D. Paramyxoviridae: the viruses and their replication. Fields of Virology 2001, vol. 1:1305-1443. Lippincott Williams & Wilkins, Philadelphia. 4th ed.
79. Ledeen R.W., Chakraborty G. Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis. Neurochem. Res. 1998, 23:277-289.
80. Levine J.M., Levine G.J., Porter B.F., Topp K., Noble-Haeusslein L.J. Naturally occurring disk herniation in dogs: an opportunity for pre-clinical spinal cord injury research. J. Neurotrauma 2011, 28:675-688.
81. Liu J.S., Amaral T.D., Brosnan C.F., Lee S.C. IFNs are critical regulators of IL-1 receptor antagonist and IL-1 expression in human microglia. J. Immunol. 1998, 161:1989-1996.
82. Lowrie M., Penderis J., McLaughlin M., Eckersall P.D., Anderson T.J. Steroid responsive meningitis-arteritis: a prospective study of potential disease markers, prednisolone treatment, and long-term outcome in 20 dogs (2006-2008). J. Vet. Intern. Med. 2009, 23:862-870.
83. Maiolini A., Carlson R., Schwartz M., Gandini G., Tipold A. Determination of immunoglobulin A concentrations in the serum and cerebrospinal fluid of dogs: an estimation of its diagnostic value in canine steroid-responsive meningitis-arteritis. Vet. J. 2012, 191:219-224.
84. Markus S., Failing K., Baumgärtner W. Increased expression of pro-inflammatory cytokines and lack of up-regulation of anti-inflammatory cytokines in early distemper CNS lesions. J. Neuroimmunol. 2002, 125:30-41.
85. Martinic M.M., von Herrath M.G. Novel strategies to eliminate persistent viral infections. Trends Immunol. 2008, 29:116-124.
86. Meric S.M. Canine meningitis. A changing emphasis. J. Vet. Intern. Med. 1988, 2:26-35.
87. Meric S.M., Perman V., Hardy R.M. Corticosteroid-responsive meningitis in ten dogs. J. Am. Anim. Hosp. Assoc. 1985, 21:677-684.
88. Merrill J.E., Benveniste E.N. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 1996, 19:331-338.
89. Mikita J., Dubourdieu-Cassagno N., Deloire M.S., Vekris A., Biran M., Raffard G., Brochet B., Canron M.H., Franconi J.M., Boiziau C., Petry K.G. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult. Scler. 2011, 17:2-15.
90. Mukaino M., Nakamura M., Yamada O., Okada S., Morikawa S., Renault-Mihara F., Iwanami A., Ikegami T., Ohsugi Y., Tsuji O., Katoh H., Matsuzaki Y., Toyama Y., Liu M., Okano H. Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation. Exp. Neurol. 2010, 224:403-414.
91. Murray P.D., McKenzie D.T., Swain S.L., Kagnoff M.F. Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. J. Immunol. 1987, 139:2669-2674.
92. Nakamura M., Okada S., Toyama Y., Okano H. Role of IL-6 in spinal cord injury in a mouse model. Clin. Rev. Allergy Immunol. 2005, 28:197-204.
93. Nesseler A., Baumgärtner W., Zurbriggen A., örvell C. Restricted virus protein translation in canine distemper virus inclusion body polioencephalitis. Vet. Microbiol. 1999, 69:23-28.
94. Olby N. Current concepts in the management of acute spinal cord injury. J. Vet. Intern. Med. 1999, 13:399-407.
95. Olby N. The pathogenesis and treatment of acute spinal cord injuries in dogs. Vet. Clin. North Am. Small Anim. Pract. 2010, 40:791-807.
96. Olson J.K. Immune response by microglia in the spinal cord. Ann. N.Y. Acad. Sci. 2010, 1198:271-278.
97. Paintlia M.K., Paintlia A.S., Singh A.K., Singh I. Synergistic activity of interleukin-17 and tumor necrosis factor-α enhances oxidative stress-mediated oligodendrocyte apoptosis. J. Neurochem. 2011, 116:508-521.
98. Paltrinieri S., Crippa A., Comerio T., Angioletti A., Roccabianca P. Evaluation of inflammation and immunity in cats with spontaneous parvovirus infection: consequences of recombinant feline interferon-omega administration. Vet. Immunol. Immunopathol. 2007, 118:68-74.
99. Pan J.Z., Ni L., Sodhi A., Aguanno A., Young W., Hart R.P. Cytokine activity contributes to induction of inflammatory cytokine mRNAs in spinal cord following contusion. J. Neurosci. Res. 2002, 68:315-322.
100. Panek R.B., Benveniste E.N. Class II MHC gene expression in microglia. Regulation by the cytokines IFN-gamma, TNFalpha, and TGF-beta. J. Immunol. 1995, 154:2846-2854.
101. Penkowa M., Giralt M., Carrasco J., Hadberg H., Hidalgo J. Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice. Glia 2000, 32:271-285.
102. Profyris C., Cheema S.S., Zang D., Azari M.F., Boyle K., Petratos S. Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol. Dis. 2004, 15:415-436.
103. Popovich P.G., Stokes B.T., Whitacre C.C. Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system. J. Neurosci. Res. 1996, 45:349-363.
104. Popovich P.G., Wei P., Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 1997, 377:443-464.
105. Puff C., Krudewig C., Imbschweiler I., Baumgärtner W., Alldinger S. Influence of persistent canine distemper virus infection on expression of RECK, matrix-metalloproteinases and their inhibitors in a canine macrophage/monocytic tumour cell line (DH82). Vet. J. 2009, 182:100-107.
106. Relton J.K., Rothwell N.J. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 1992, 29:243-246.
107. Righi M., Mori L., De Libero G., Sironi M., Biondi A., Mantovani A., Donini S.D., Ricciardi-Castagnoli P. Monokine production by microglial cell clones. Eur. J. Immunol. 1989, 19:1443-1448.
108. Rothwell N.J., Hopkins S.J. Cytokines and the nervous system. II. Actions and mechanisms of action. Trends Neurosci. 1995, 18:130-136.
109. Rowley A.H., Eckerley C.A., Jäck H.M., Shulman S.T., Baker S.C. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J. Immunol. 1997, 159:5946-5955.
110. Rudd P.A., Bastien-Hamel L.E., von Messling V. Acute canine distemper encephalitis is associated with rapid neuronal loss and local immune activation. J. Gen. Virol. 2010, 91:980-989.
111. Sakaguchi S., Wing K., Onishi Y., Prieto-Martin P., Yamaguchi T. Regulatory T cells: how do they suppress immune responses?. Int. Immunol. 2009, 21:1105-1111.
112. Schmitt A.B., Buss A., Breuer S., Brook G.A., Pech K., Martin D., Schoenen J., Noth J., Love S., Schröder J.M., Kreutzberg G.W., Nacimiento W. Major histocompatibility complex class II expression by activated microglia caudal to lesions of descending tracts in the human spinal cord is not associated with a T cell response. Acta Neuropathol. 2000, 100:528-536.
113. Schwab S., Herden C., Seeliger F., Papaioannou N., Psalla D., Polizopulou Z., Baumgärtner W. Non-suppurative meningoencephalitis of unknown origin in cats and dogs: an immunohistochemical study. J. Comp. Pathol. 2007, 136:96-110.
114. Schwartz M., Carlson R., Tipold A. Selective CD11a upregulation on neutrophils in the acute phase of steroid-responsive meningitis-arteritis in dogs. Vet. Immunol. Immunopathol. 2008, 126:248-255.
115. Schwartz M., Moore P.F., Tipold A. Disproportionally strong increase of B cells in inflammatory cerebrospinal fluid of dogs with steroid-responsive meningitis-arteritis. Vet. Immunol. Immunopathol. 2008, 125:274-283.
116. Schwartz M., Kipnis J. Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries. Trends Mol. Med. 2001, 7:252-258.
117. Schwartz M., Puff C., Stein V.M., Baumgärtner W., Tipold A. Marked MMP-2 transcriptional up-regulation in mononuclear leukocytes invading the subarachnoidal space in aseptic suppurative steroid-responsive meningitis-arteritis in dogs. Vet. Immunol. Immunopathol. 2010, 133:198-206.
118. Schwartz M., Puff C., Stein V.M., Baumgärtner W., Tipold A. Pathogenetic factors for excessive IgA production: Th2-dominated immune response in canine steroid-responsive meningitis-arteritis. Vet. J. 2011, 187:260-266.
119. Scott-Moncrieff J.C., Snyder P.W., Glickman L.T., Davis E.L., Felsburg P.J. Systemic necrotizing vasculitis in nine young beagles. J. Am. Vet. Med. Assoc. 1992, 201:1553-1558.
120. Sethi G., Sung B., Kunnumakkara A.B., Aggarwal B.B. Targeting TNF for Treatment of Cancer and Autoimmunity. Adv. Exp. Med. Biol. 2009, 647:37-51.
121. Smith D. Interferon-beta therapy for multiple sclerosis-is the injection site the relevant action site?. J. Neuroimmunol. 2009, 215:117-121.
122. Smith P.M., Lakatos A., Barnett S.C., Jeffery N.D., Franklin R.J. Cryopreserved cells isolated from the adult canine olfactory bulb are capable of extensive remyelination following transplantation into the adult rat CNS. Exp. Neurol. 2002, 176:402-406.
123. Smith P.M., Jeffery N.D. Histological and ultrastructural analysis of white matter damage after naturally-occurring spinal cord injury. Brain Pathol. 2006, 16:99-109.
124. Snyder P.W., Kazacos E.A., Scott-Moncrieff J.C., HogenEsch H., Carlton W.W., Glickman L.T., Felsburg P.J. Pathologic features of naturally occurring juvenile polyarteritis in beagle dogs. Vet. Pathol. 1995, 32:337-345.
125. Solomon A.J., Spain R.I., Kruer M.C., Bourdette D. Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors. Mult. Scler. 2011, 17:1472-1487.
126. Sottini A., Capra R., Serana F., Chiarini M., Caimi L., Imberti L. Interferon-beta therapy monitoring in multiple sclerosis patients. Endocr. Metab. Immune Disord. Drug Targets 2009, 9:14-28.
127. Spitzbarth I., Bock P., Haist V., Stein V.M., Tipold A., Wewetzer K., Baumgärtner W., Beineke A. Prominent microglial activation in the early proinflammatory immune response in naturally occurring canine spinal cord injury. J. Neuropathol. Exp. Neurol. 2011, 70:703-714.
128. Spitzbarth I., Schenk H.C., Tipold A., Beineke A. Immunohistochemical characterization of inflammatory and glial responses in a case of necrotizing leucoencephalitis in a French bulldog. J. Comp. Pathol. 2010, 142:235-241.
129. Spulber S., Bartfai T., Schultzberg M. IL-1/IL-1ra balance in the brain revisited-evidence from transgenic mouse models. Brain Behav. Immun. 2009, 23:573-579.
130. Stein V.M., Czub M., Hansen R., Leibold W., Moore P.F., Zurbriggen A., Tipold A. Characterization of canine microglial cells isolated ex vivo. Vet. Immunol. Immunopathol. 2004, 99:73-85.
131. Stein V.M., Czub M., Schreiner N., Moore P.F., Vandevelde M., Zurbriggen A., Tipold A. Microglial cell activation in demyelinating canine distemper lesions. J. Neuroimmunol. 2004, 153:122-131.
132. Stein V.M., Baumgärtner W., Kreienbrock L., Zurbriggen A., Vandevelde M., Tipold A. Canine microglial cells: stereotypy in immunophenotype and specificity in function?. Vet. Immunol. Immunopathol. 2006, 113:277-287.
133. Stein V.M., Baumgärtner W., Schröder S., Zurbriggen A., Vandevelde M., Tipold A. Differential expression of CD45 on canine microglial cells. J. Vet. Med. A: Physiol. Pathol. Clin. Med. 2007, 54:314-320.
134. Stein V.M., Puff C., Genini S., Contioso V.B., Baumgärtner W., Tipold A. Variations on brain microglial gene expression of MMPs, RECK, and TIMPs in inflammatory and non-inflammatory diseases in dogs. Vet. Immunol. Immunopathol. 2011, 144:17-26.
135. Sugiura K., Wijewardana V., Fujimoto M., Akazawa T., Yahata M., Mito K., Hatoya S., Inoue N., Inaba T. Effect of IL-12 on canine dendritic cell maturation following differentiation induced by granulocyte-macrophage CSF and IL-4. Vet. Immunol. Immunopathol. 2010, 137:322-326.
136. Talarico L.R., Schatzberg S.J. Idiopathic granulomatous and necrotising inflammatory disorders of the canine central nervous system: a review and future perspectives. J. Small Anim. Pract. 2010, 51:138-149.
137. Tipold A. Diagnosis of inflammatory and infectious diseases of the central nervous system in dogs: a retrospective study. J. Vet. Intern. Med. 1995, 9:304-314.
138. Tipold A., Jaggy A. Steroid responsive meningitis-arteritis in dogs: long-term study of 32 cases. J. Small Anim. Pract. 1994, 35:311-316.
139. Tipold A., Schatzberg S.J. An update on steroid responsive meningitis-arteritis. J. Small Anim. Pract. 2010, 51:150-154.
140. Tipold A., Stein V.M. Inflammatory diseases of the spine in small animals. Vet. Clin. North Am. Small Anim. Pract. 2011, 40:871-879.
141. Tipold A., Pfister H., Zurbriggen A., Vandevelde M. Intrathecal synthesis of major immunoglobulin classes in inflammatory diseases of the canine CNS. Vet. Immunol. Immunopathol. 1994, 42:149-159.
142. Tipold A., Vandevelde M., Zurbriggen A. Neuroimmunological studies in steroid-responsive meningitis-arteritis in dogs. Res. Vet. Sci. 1995, 58:103-108.
143. Tipold A., Moore P., Zurbriggen A., Burgener I., Barben G., Vandevelde M. Early T cell response in the central nervous system in canine distemper virus infection. Acta Neuropathol. 1999, 97:45-56.
144. Tipold A., Moore P., Zurbriggen A., Vandevelde M. Lymphocyte subset distribution in steroid responsive meningitis-arteritis in comparison to different canine encephalitides. Zentralbl. Veterinarmed. 1999, 46:75-85.
145. Tipold A., Vandevelde M., Wittek R., Moore P., Summerfield A., Zurbriggen A. Partial protection and intrathecal invasion of CD8(+) T cells in acute canine distemper virus infection. Vet. Microbiol. 2001, 83:189-203.
146. Tsai S.C., Summers B.A., Appel M.J. Interferon in cerebrospinal fluid. A marker for viral persistence of canine distemper encephalomyelitis. Arch. Virol. 1982, 72:257-265.
147. Tsai M.C., Wei C.P., Lee D.Y., Tseng Y.T., Tsai M.D., Shih Y.L., Lee Y.H., Chang S.F., Leu S.J. Inflammatory mediators of cerebrospinal fluid from patients with spinal cord injury. Surg. Neurol. 2008, 70:19-24.
148. Tuttolomondo A., Di Raimondo D., di Sciacca R., Pinto A., Licata G. Inflammatory cytokines in acute ischemic stroke. Curr. Pharm. Des. 2008, 14:3574-3589.
149. Tyor W.R., Avgeropoulos N., Ohlandt G., Hogan E.L. Treatment of spinal cord impact injury in the rat with transforming growth factor-beta. J. Neurol. Sci. 2002, 200:33-41.
150. Valli J.L., Williamson A., Sharif S., Rice J., Shewen P.E. In vitro cytokine responses of peripheral blood mononuclear cells from healthy dogs to distemper virus, Malassezia and Toxocara. Vet. Immunol. Immunopathol. 2010, 134:218-229.
151. Vandenbroeck K., Alloza I., Gadina M., Matthys P. Inhibiting cytokines of the interleukin-12 family: recent advances and novel challenges. J. Pharm. Pharmacol. 2004, 56:145-160.
152. Vandevelde M. Molecular mechanisms in CNS injury-the importance of therapeutic modification of cytokine expression in the brains of domestic animals. Vet. J. 2004, 168:205-206.
153. Vandevelde M., Zurbriggen A. Demyelination in canine distemper virus infection: a review. Acta Neuropathol. 2005, 109:56-68.
154. Vandevelde M., Fankhauser R., Kristensen F., Kristensen B. Immunoglobulins in demyelinating lesions in canine distemper encephalitis. An immunohistological study. Acta Neuropathol. 1981, 54:31-41.
155. Vandevelde M., Kristensen F., Kristensen B., Steck A.J., Kihm U. Immunological and pathological findings in demyelinating encephalitis associated with canine distemper virus infection. Acta Neuropathol. 1982, 56:1-8.
156. Von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 2005, 6:338-344.
157. Wang C.X., Shuaib A. Involvement of inflammatory cytokines in central nervous system injury. Prog. Neurobiol. 2002, 67:161-172.
158. Wang C.X., Nuttin B., Heremans H., Dom R., Gybels J. Production of tumor necrosis factor in spinal cord following traumatic injury in rats. J. Neuroimmunol. 1996, 69:151-156.
159. Wang C.X., Olschowka J.A., Wrathall J.R. Increase of interleukin-1beta mRNA and protein in the spinal cord following experimental traumatic injury in the rat. Brain Res. 1997, 759:190-196.
160. Wang X.F., Huang L.D., Yu P.P., Hu J.G., Yin L., Wang L., Xu X.M., Lu P.H. Upregulation of type I interleukin-1 receptor after traumatic spinal cord injury in adult rats. Acta Neuropathol. 2006, 111:220-228.
161. Webb A.A., Muir G.D. The blood-brain barrier and its role in inflammation. J. Vet. Intern. Med. 2000, 14:399-411.
162. Wewetzer K., Radtke C., Kocsis J., Baumgärtner W. Species-specific control of cellular proliferation and the impact of large animal models for the use of olfactory ensheathing cells and Schwann cells in spinal cord repair. Exp. Neurol. 2011, 229:80-87.
163. Wrzosek M., Konar M., Vandevelde M., Oevermann A. Cerebral extension of steroid-responsive meningitis arteritis in a boxer. J. Small Anim. Pract. 2009, 50:35-37.
164. Wünschmann A., Alldinger S., Kremmer E., Baumgärtner W. Identification of CD4+ and CD8+ cell subsets and B cells in the brain of dogs with spontaneous acute, subacute-, and chronic-demyelinating distemper encephalitis. Vet. Immunol. Immunopathol. 1999, 67:101-116.
165. Wünschmann A., Kremmer E., Baumgärtner W. Phenotypical characterization of T and B cell areas in lymphoid tissues of dogs with spontaneous distemper. Vet. Immunol. Immunopathol. 2000, 73:83-98.
166. Yang L., Jones N.R., Blumbergs P.C., Van Den Heuvel C., Moore E.J., Manavis J., Sarvestani G.T., Ghabriel M.N. Severity-dependent expression of pro-inflammatory cytokines in traumatic spinal cord injury in the rat. J. Clin. Neurosci. 2005, 12:276-284.
167. Yu C.H., Yhee J.Y., Kim J.H., Im K.S., Kim N.H., Jung D.I., Lee H.C., Chon S.K., Sur J.H. Pro- and anti-inflammatory cytokine expression and histopathological characteristics in canine brain with traumatic brain injury. J. Vet. Sci. 2011, 12:299-301.
168. Zhang X., Markovic-Plese S. Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing-remitting multiple sclerosis. Clin. Neurol. Neurosurg. 2010, 112:641-645.
169. Zhou Z., Peng X., Insolera R., Fink D.J., Mata M. IL-10 promotes neuronal survival following spinal cord injury. Exp. Neurol. 2009, 220:183-190.